CS262448B2 - Process for preparing derivatives of n-/2-aminophenyl/-benzamide - Google Patents

Process for preparing derivatives of n-/2-aminophenyl/-benzamide Download PDF

Info

Publication number
CS262448B2
CS262448B2 CS872736A CS273687A CS262448B2 CS 262448 B2 CS262448 B2 CS 262448B2 CS 872736 A CS872736 A CS 872736A CS 273687 A CS273687 A CS 273687A CS 262448 B2 CS262448 B2 CS 262448B2
Authority
CS
Czechoslovakia
Prior art keywords
benzamide
aminophenyl
starting materials
formula
compound
Prior art date
Application number
CS872736A
Other languages
Czech (cs)
English (en)
Other versions
CS273687A2 (en
Inventor
Ute Weiershausen
Gerhard Dr Satzinger
Karl-Otto Dr Vollmer
Wolfgang Dr Herrmann
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19863613571 external-priority patent/DE3613571A1/de
Priority claimed from DE19863625359 external-priority patent/DE3625359A1/de
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of CS273687A2 publication Critical patent/CS273687A2/cs
Publication of CS262448B2 publication Critical patent/CS262448B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS872736A 1986-04-22 1987-04-16 Process for preparing derivatives of n-/2-aminophenyl/-benzamide CS262448B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863613571 DE3613571A1 (de) 1986-04-22 1986-04-22 N-(2'-aminophenyl)-benzamid-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung neoplastischer erkrankungen
DE19863625359 DE3625359A1 (de) 1986-07-26 1986-07-26 N-(2'-aminophenyl)-benzamid-derivat, verfahren zu dessen herstellung und dessen verwendung bei der bekaempfung neoplastischer erkrankungen

Publications (2)

Publication Number Publication Date
CS273687A2 CS273687A2 (en) 1988-07-15
CS262448B2 true CS262448B2 (en) 1989-03-14

Family

ID=25843119

Family Applications (1)

Application Number Title Priority Date Filing Date
CS872736A CS262448B2 (en) 1986-04-22 1987-04-16 Process for preparing derivatives of n-/2-aminophenyl/-benzamide

Country Status (19)

Country Link
US (1) US5137918A (no)
EP (1) EP0242851B1 (no)
JP (1) JPH0825977B2 (no)
CN (1) CN1012498B (no)
AT (1) AT388913B (no)
CA (1) CA1334760C (no)
CS (1) CS262448B2 (no)
DE (1) DE3763191D1 (no)
DK (1) DK170771B1 (no)
ES (1) ES2095824T3 (no)
FI (1) FI87766C (no)
GR (1) GR3000562T3 (no)
HU (1) HU197295B (no)
IE (1) IE60332B1 (no)
IL (1) IL82265A (no)
NO (1) NO168353C (no)
NZ (1) NZ219974A (no)
PH (1) PH23928A (no)
PT (1) PT84737B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
WO1998047500A1 (en) * 1997-04-24 1998-10-29 Warner-Lambert Company Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
ES2185378T3 (es) * 1998-09-25 2003-04-16 Warner Lambert Co Quimioterapia de cancer con acetildinalina en combinacion con gemcitabina, capecitabina o cisplatina.
JP2003513912A (ja) * 1999-11-10 2003-04-15 ワーナー−ランバート・カンパニー 組合せ化学療法
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
AR034897A1 (es) 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
CN101851173A (zh) * 2001-09-14 2010-10-06 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
US7868204B2 (en) * 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
US6897220B2 (en) * 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
GB0202873D0 (en) * 2002-02-07 2002-03-27 Novartis Ag Organic compounds
TW200426138A (en) 2002-12-10 2004-12-01 Hoffmann La Roche Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives, their manufacture and use as pharmaceutical agents
TW200424174A (en) 2003-02-06 2004-11-16 Hoffmann La Roche New TP diamide
US7208491B2 (en) 2003-02-07 2007-04-24 Hoffmann-La Roche Inc. N-monoacylated o-phenylenediamines
TW200424187A (en) 2003-04-04 2004-11-16 Hoffmann La Roche New oxime derivatives and their use as pharmaceutically active agents
US7868205B2 (en) * 2003-09-24 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
CA2552279C (en) * 2003-12-02 2014-07-15 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
US7253204B2 (en) * 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
AU2007234843B2 (en) * 2006-04-07 2013-07-11 Methylgene Inc. Inhibitors of histone deacetylase
US7960434B2 (en) * 2006-05-19 2011-06-14 University Of South Florida Small molecule inhibitors of STAT3 with anti-tumor activity
WO2009076234A2 (en) * 2007-12-07 2009-06-18 University Of Maryland, Baltimore Synthesis methods of histone deacetylase inhibitors (hdacis)
WO2010036404A2 (en) * 2008-05-09 2010-04-01 University Of Maryland, Baltimore Novel retinamide retinoic acid metabolism blocking agents
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
TW201031675A (en) 2008-12-23 2010-09-01 Pharmasset Inc Synthesis of purine nucleosides
US8551973B2 (en) 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
AU2009329867B2 (en) 2008-12-23 2015-01-29 Gilead Pharmasset Llc Nucleoside phosphoramidates
HUE026235T2 (en) 2010-03-31 2016-06-28 Gilead Pharmasset Llc Crystalline (S) -isopropyl 2 - (((S) - (((2R, 3R, 4R, 5R) -5- (2,4-dioxo-3,4-dihydropyrimidin-1 (2H) -IL) - 4-Fluoro-3-hydroxy-4-methyltetrahydrofuran-2-IL) methoxy) (phenoxy) phosphoryl) amino) propanoate
EP2712655B1 (en) 2011-04-28 2019-12-18 The Broad Institute, Inc. Inhibitors of histone deacetylase
US8691875B2 (en) 2011-07-01 2014-04-08 Broad Institute, Inc. Solid forms of tacedinaline
US9790184B2 (en) * 2012-07-27 2017-10-17 The Broad Institute, Inc. Inhibitors of histone deacetylase
WO2014100438A1 (en) 2012-12-20 2014-06-26 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
US9636298B2 (en) 2014-01-17 2017-05-02 Methylgene Inc. Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
CN104058983B (zh) * 2014-07-02 2016-01-13 郑攀锋 一种医药原料酰胺类化合物的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1493783A1 (de) * 1965-07-12 1969-01-30 Goedecke Ag Verfahren zur Herstellung von 2-Amino-4'-(diaethylamino)-2'-methyl-benzanilid
DE1643264A1 (de) * 1967-12-20 1971-06-09 Basf Ag Verfahren zur Herstellung von Aminoaniliden
US4004029A (en) * 1974-05-13 1977-01-18 The Upjohn Company Compositions and method for treating epilepsy and convulsions
DE3305755A1 (de) * 1983-02-19 1984-08-23 Gödecke AG, 1000 Berlin N-phenyl-benzamid-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkranungen des immunsystems
CH653670A5 (de) * 1983-03-03 1986-01-15 Hoffmann La Roche Benzamid-derivate.
US4642379A (en) * 1985-08-30 1987-02-10 Eli Lilly And Company Intermediates for anticonvulsant agents

Also Published As

Publication number Publication date
FI87766B (fi) 1992-11-13
PT84737B (pt) 1989-12-29
FI87766C (fi) 1993-02-25
ATA265187A (de) 1989-02-15
DK170771B1 (da) 1996-01-15
NZ219974A (en) 1989-08-29
IL82265A0 (en) 1987-10-30
JPS63115852A (ja) 1988-05-20
IE871046L (en) 1987-10-22
FI871733A (fi) 1987-10-23
NO168353B (no) 1991-11-04
HU197295B (en) 1989-03-28
HUT43808A (en) 1987-12-28
PH23928A (en) 1990-01-23
IL82265A (en) 1991-01-31
NO871640L (no) 1987-10-23
US5137918A (en) 1992-08-11
GR3000562T3 (en) 1991-07-31
CS273687A2 (en) 1988-07-15
CA1334760C (en) 1995-03-14
IE60332B1 (en) 1994-06-29
JPH0825977B2 (ja) 1996-03-13
NO168353C (no) 1992-02-12
EP0242851A1 (de) 1987-10-28
EP0242851B1 (de) 1990-06-13
CN87103096A (zh) 1987-11-18
CN1012498B (zh) 1991-05-01
DK198487A (da) 1987-10-23
NO871640D0 (no) 1987-04-21
FI871733A0 (fi) 1987-04-21
ES2095824T3 (es) 1997-03-01
DK198487D0 (da) 1987-04-15
AT388913B (de) 1989-09-25
DE3763191D1 (de) 1990-07-19
PT84737A (en) 1987-05-01

Similar Documents

Publication Publication Date Title
CS262448B2 (en) Process for preparing derivatives of n-/2-aminophenyl/-benzamide
EP0471236B1 (en) Imidazopyridine derivatives and their use
KR101118807B1 (ko) Ｏ-치환 히드록시아릴 유도체
EP0540544B1 (en) Benzoic acid substituted derivatives having cardiovascular activity
JP4676884B2 (ja) シクロヘキサンカルボン酸類
RU2045522C1 (ru) Диаминовые соединения или их кислотно-аддитивные соли
UA43841C2 (uk) Імідазопіридини та фармацевтична композиція на їх основі
EA003924B1 (ru) Арилсульфонанилидмочевины
JPS59163356A (ja) Ｎ−フエニルベンズアミド誘導体ならびにその製造法および応用
JPS61109766A (ja) アダマンタンアミン誘導体、その製造方法及びそれを含む医薬
JP3009196B2 (ja) 抗ウイルス活性を有する薬剤、燐脂質誘導体及びその製造方法
KR860001389B1 (ko) 나트로안식향산 아미드 유도체의 제조방법
EP0221511B1 (en) 2-aminosulfonyl-6-nitrobenzoic esters or amides, process for their preparation and pharmaceutical compositions containing them
KR20010013164A (ko) 세포 증식 억제제로서의 시아노구아니딘
HU210683B (en) Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
EP0197386B1 (en) 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
CS244814B2 (en) Production method of 4-oxothiazolidi-2-ylidenacetamide
EP0200134B1 (en) 5,6-Dihydroimidazo[2,1-b]thiazole-2-carboxamide derivatives or salts thereof
FR2824559A1 (fr) Nouveaux derives 5-thio-beta-xylopyronasides, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique
US2695293A (en) N, n'-substituted diamine compounds and method of making the same
SK67093A3 (en) Phospholipide derivatives, method of their production and purifying, medicine and method of its production
EP0133934A2 (en) Pharmacologically active 1,3,4-thiadiazol-(3,2-a)-thieno-(2,3-d)-pyrimidin-5-(H)one derivatives
US3927001A (en) D-glucaro-1,5-lactam derivatives
JPS591268B2 (ja) チアジアゾ−ル誘導体
EP0101633B1 (en) Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20020416